[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.191.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 683
Citations 0
Research Letter
February 6, 2020

Random vs Targeted Urine Drug Testing Among Patients Undergoing Long-term Opioid Treatment for Cancer Pain

Author Affiliations
  • 1Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston
  • 2Department of Oncology and Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
JAMA Oncol. Published online February 6, 2020. doi:10.1001/jamaoncol.2019.6756

There is limited information on best practices regarding urine drug testing (UDT) during long-term opioid therapy for cancer pain.1 Practices involve random UDT1 or UDT based on risk for nonmedical opioid use.2 The main objective of this study was to report the frequency of abnormal UDT findings among patients who underwent random vs targeted testing.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×